Status:
RECRUITING
Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy
Lead Sponsor:
Assiut University
Conditions:
Intraoperative Blood Loss
Pediatric
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
Surgical hip reconstruction reduces the hip joint through soft tissue releases and osteotomies of the femur and/or pelvis. Blood loss and subsequent blood transfusion are normal consequences of hip re...
Detailed Description
the use of antifibrinolytics (AFs) to limit blood loss peri-operatively has been popularized in certain subspecialties. AFs have been studied extensively in adults undergoing various orthopedic proced...
Eligibility Criteria
Inclusion
- ASA I - II
- Scheduled for acetabular osteotomy and/or proximal femoral derotation osteotomies.
Exclusion
- Patient's guardian refusal to participate in the study.
- Children known to have pre-existing bleeding or coagulation disorders.
- Children with anemia; defined according to (WHO ) cutoffs as Hb level\<11g/dl for girls and \<12g/dl for boys
- History of epilepsy.
- History of renal insufficiency or failure
Key Trial Info
Start Date :
April 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04811313
Start Date
April 3 2025
End Date
March 1 2026
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt, 71515